Literature DB >> 29700067

Epigenomics: Technologies and Applications.

Kevin C Wang1, Howard Y Chang2,3.   

Abstract

The advent of high-throughput epigenome mapping technologies has ushered in a new era of multiomics where powerful tools can now delineate and record different layers of genomic output. Integrating various components of the epigenome from these multiomics measurements allows the interrogation of cellular heterogeneity in addition to the discovery of molecular connectivity maps between the genome and its functional output. Mapping of chromatin accessibility dynamics and higher-order chromatin structure has enabled new levels of understanding of cell fate decisions, identity, and function in normal development, physiology, and disease. We provide a perspective on the progress of the epigenomics field and applications and anticipate an even greater revolution in our understanding of the human epigenome for years to come.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  chromatin; epigenomics; genomics; humans

Mesh:

Substances:

Year:  2018        PMID: 29700067      PMCID: PMC5929475          DOI: 10.1161/CIRCRESAHA.118.310998

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  78 in total

1.  The genome shows its sensitive side.

Authors:  Anil Raj; Graham McVicker
Journal:  Nat Methods       Date:  2014-01       Impact factor: 28.547

Review 2.  Advantages of next-generation sequencing versus the microarray in epigenetic research.

Authors:  Paul J Hurd; Christopher J Nelson
Journal:  Brief Funct Genomic Proteomic       Date:  2009-06-17

Review 3.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

Review 4.  Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.

Authors:  Janika Viereck; Thomas Thum
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

5.  Large-scale association analysis identifies new risk loci for coronary artery disease.

Authors:  Panos Deloukas; Stavroula Kanoni; Christina Willenborg; Martin Farrall; Themistocles L Assimes; John R Thompson; Erik Ingelsson; Danish Saleheen; Jeanette Erdmann; Benjamin A Goldstein; Kathleen Stirrups; Inke R König; Jean-Baptiste Cazier; Asa Johansson; Alistair S Hall; Jong-Young Lee; Cristen J Willer; John C Chambers; Tõnu Esko; Lasse Folkersen; Anuj Goel; Elin Grundberg; Aki S Havulinna; Weang K Ho; Jemma C Hopewell; Niclas Eriksson; Marcus E Kleber; Kati Kristiansson; Per Lundmark; Leo-Pekka Lyytikäinen; Suzanne Rafelt; Dmitry Shungin; Rona J Strawbridge; Gudmar Thorleifsson; Emmi Tikkanen; Natalie Van Zuydam; Benjamin F Voight; Lindsay L Waite; Weihua Zhang; Andreas Ziegler; Devin Absher; David Altshuler; Anthony J Balmforth; Inês Barroso; Peter S Braund; Christof Burgdorf; Simone Claudi-Boehm; David Cox; Maria Dimitriou; Ron Do; Alex S F Doney; NourEddine El Mokhtari; Per Eriksson; Krista Fischer; Pierre Fontanillas; Anders Franco-Cereceda; Bruna Gigante; Leif Groop; Stefan Gustafsson; Jörg Hager; Göran Hallmans; Bok-Ghee Han; Sarah E Hunt; Hyun M Kang; Thomas Illig; Thorsten Kessler; Joshua W Knowles; Genovefa Kolovou; Johanna Kuusisto; Claudia Langenberg; Cordelia Langford; Karin Leander; Marja-Liisa Lokki; Anders Lundmark; Mark I McCarthy; Christa Meisinger; Olle Melander; Evelin Mihailov; Seraya Maouche; Andrew D Morris; Martina Müller-Nurasyid; Kjell Nikus; John F Peden; N William Rayner; Asif Rasheed; Silke Rosinger; Diana Rubin; Moritz P Rumpf; Arne Schäfer; Mohan Sivananthan; Ci Song; Alexandre F R Stewart; Sian-Tsung Tan; Gudmundur Thorgeirsson; C Ellen van der Schoot; Peter J Wagner; George A Wells; Philipp S Wild; Tsun-Po Yang; Philippe Amouyel; Dominique Arveiler; Hanneke Basart; Michael Boehnke; Eric Boerwinkle; Paolo Brambilla; Francois Cambien; Adrienne L Cupples; Ulf de Faire; Abbas Dehghan; Patrick Diemert; Stephen E Epstein; Alun Evans; Marco M Ferrario; Jean Ferrières; Dominique Gauguier; Alan S Go; Alison H Goodall; Villi Gudnason; Stanley L Hazen; Hilma Holm; Carlos Iribarren; Yangsoo Jang; Mika Kähönen; Frank Kee; Hyo-Soo Kim; Norman Klopp; Wolfgang Koenig; Wolfgang Kratzer; Kari Kuulasmaa; Markku Laakso; Reijo Laaksonen; Ji-Young Lee; Lars Lind; Willem H Ouwehand; Sarah Parish; Jeong E Park; Nancy L Pedersen; Annette Peters; Thomas Quertermous; Daniel J Rader; Veikko Salomaa; Eric Schadt; Svati H Shah; Juha Sinisalo; Klaus Stark; Kari Stefansson; David-Alexandre Trégouët; Jarmo Virtamo; Lars Wallentin; Nicholas Wareham; Martina E Zimmermann; Markku S Nieminen; Christian Hengstenberg; Manjinder S Sandhu; Tomi Pastinen; Ann-Christine Syvänen; G Kees Hovingh; George Dedoussis; Paul W Franks; Terho Lehtimäki; Andres Metspalu; Pierre A Zalloua; Agneta Siegbahn; Stefan Schreiber; Samuli Ripatti; Stefan S Blankenberg; Markus Perola; Robert Clarke; Bernhard O Boehm; Christopher O'Donnell; Muredach P Reilly; Winfried März; Rory Collins; Sekar Kathiresan; Anders Hamsten; Jaspal S Kooner; Unnur Thorsteinsdottir; John Danesh; Colin N A Palmer; Robert Roberts; Hugh Watkins; Heribert Schunkert; Nilesh J Samani
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

Review 6.  MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease.

Authors:  Eric N Olson
Journal:  Sci Transl Med       Date:  2014-06-04       Impact factor: 17.956

7.  Architecture of the human regulatory network derived from ENCODE data.

Authors:  Mark B Gerstein; Anshul Kundaje; Manoj Hariharan; Stephen G Landt; Koon-Kiu Yan; Chao Cheng; Xinmeng Jasmine Mu; Ekta Khurana; Joel Rozowsky; Roger Alexander; Renqiang Min; Pedro Alves; Alexej Abyzov; Nick Addleman; Nitin Bhardwaj; Alan P Boyle; Philip Cayting; Alexandra Charos; David Z Chen; Yong Cheng; Declan Clarke; Catharine Eastman; Ghia Euskirchen; Seth Frietze; Yao Fu; Jason Gertz; Fabian Grubert; Arif Harmanci; Preti Jain; Maya Kasowski; Phil Lacroute; Jing Jane Leng; Jin Lian; Hannah Monahan; Henriette O'Geen; Zhengqing Ouyang; E Christopher Partridge; Dorrelyn Patacsil; Florencia Pauli; Debasish Raha; Lucia Ramirez; Timothy E Reddy; Brian Reed; Minyi Shi; Teri Slifer; Jing Wang; Linfeng Wu; Xinqiong Yang; Kevin Y Yip; Gili Zilberman-Schapira; Serafim Batzoglou; Arend Sidow; Peggy J Farnham; Richard M Myers; Sherman M Weissman; Michael Snyder
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

Review 8.  Three-dimensional genome architecture: players and mechanisms.

Authors:  Ana Pombo; Niall Dillon
Journal:  Nat Rev Mol Cell Biol       Date:  2015-03-11       Impact factor: 94.444

9.  Repurposing the CRISPR-Cas9 system for targeted DNA methylation.

Authors:  Aleksandar Vojta; Paula Dobrinić; Vanja Tadić; Luka Bočkor; Petra Korać; Boris Julg; Marija Klasić; Vlatka Zoldoš
Journal:  Nucleic Acids Res       Date:  2016-03-11       Impact factor: 16.971

10.  Manipulation of nuclear architecture through CRISPR-mediated chromosomal looping.

Authors:  Stefanie L Morgan; Natasha C Mariano; Abel Bermudez; Nicole L Arruda; Fangting Wu; Yunhai Luo; Gautam Shankar; Lin Jia; Huiling Chen; Ji-Fan Hu; Andrew R Hoffman; Chiao-Chain Huang; Sharon J Pitteri; Kevin C Wang
Journal:  Nat Commun       Date:  2017-07-13       Impact factor: 14.919

View more
  20 in total

1.  Omics, Big Data, and Precision Medicine in Cardiovascular Sciences.

Authors:  Edward Lau; Joseph C Wu
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

2.  Transcriptional Silencers in Drosophila Serve a Dual Role as Transcriptional Enhancers in Alternate Cellular Contexts.

Authors:  Stephen S Gisselbrecht; Alexandre Palagi; Jesse V Kurland; Julia M Rogers; Hakan Ozadam; Ye Zhan; Job Dekker; Martha L Bulyk
Journal:  Mol Cell       Date:  2019-11-05       Impact factor: 17.970

Review 3.  Advances and Trends in Omics Technology Development.

Authors:  Xiaofeng Dai; Li Shen
Journal:  Front Med (Lausanne)       Date:  2022-07-01

Review 4.  Insights into rheumatic diseases from next-generation sequencing.

Authors:  Laura T Donlin; Sung-Ho Park; Eugenia Giannopoulou; Aleksandra Ivovic; Kyung-Hyun Park-Min; Richard M Siegel; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2019-06       Impact factor: 20.543

5.  Integrative omics - An arsenal for drug discovery.

Authors:  Rahul Soloman Singh; Vani Angra; Ashutosh Singh; Gladson David Masih; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2022 Jan-Feb       Impact factor: 2.833

Review 6.  The Need for Multi-Omics Biomarker Signatures in Precision Medicine.

Authors:  Michael Olivier; Reto Asmis; Gregory A Hawkins; Timothy D Howard; Laura A Cox
Journal:  Int J Mol Sci       Date:  2019-09-26       Impact factor: 5.923

7.  Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease.

Authors:  Sadhan Das; Marpadga A Reddy; Rama Natarajan
Journal:  Curr Opin Cardiol       Date:  2020-05       Impact factor: 2.108

8.  Diagnostic, progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma.

Authors:  Zhizhi Zhuang; Liping Chen; Yuting Mao; Qun Zheng; Huiying Li; Yueyue Huang; Zijing Hu; Yi Jin
Journal:  Int J Biol Sci       Date:  2020-03-25       Impact factor: 6.580

Review 9.  Multi-Omics Analysis in Initiation and Progression of Meningiomas: From Pathogenesis to Diagnosis.

Authors:  Jiachen Liu; Congcong Xia; Gaiqing Wang
Journal:  Front Oncol       Date:  2020-08-28       Impact factor: 6.244

10.  Disruption by SaCas9 Endonuclease of HERV-Kenv, a Retroviral Gene with Oncogenic and Neuropathogenic Potential, Inhibits Molecules Involved in Cancer and Amyotrophic Lateral Sclerosis.

Authors:  Gabriele Ibba; Claudia Piu; Elena Uleri; Caterina Serra; Antonina Dolei
Journal:  Viruses       Date:  2018-08-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.